Monday, 10 August 2015

Buy short sell long

The biochemial industries are on the down slide to oblivion! High Intensity UltraSound cures cancers, heart disease, diabetes, mental health problems, sttrokes and head injuries plus all infections.
The structure causing all these problems must have an overinflated nature in order to grow. Body cells bud off the stem cells, so are more flaccid.
Medics demonstrated this in the a950s, when they found low intensity ultrasound caused all cancer (And the other diseases above) to give off X-rays. As they did biological Molecular Nuclear Fusion
1 H2O+US ->He+O+E2+Xray
Then in 2002 the Moffitt cancer centre applied High Intensity UltraSound to cancer. And in a single appointment, blew the cancer cell apart. Causing minimal body cell damage. Just enough to set off a body wide immune action to clear that now dangerous cell type.
This made biochemical treatments defective medicine – globally prohibited by the Hippocratic oath. Warranting striking off of prescribing medics. This has not prevented biochemical treatments being used to kill ½ a billion people around the globe.
HIUS to the top left of the chest and the kidneys clears coronary heart disease – as medics published 2012. Again science ignored by global Gps. Who resorted to prescribing now defective biochemistry. Medical unethical – and just plain criminal.
HIUS to the bottom right of the rib cage clears diabetes – though type 1 takes 3 days to remit from a single HIUS session: I use 5 W 1 M Hz from an ultrasound massage device purchased over the internet as my HIUS device. 100% effective.
Applied to the chest throat and nose, it will clear all infections. Thus antibody manufactures are now selling defective medicine. No registered doctor can prescribe any biochemistry.
So biochemistry is seeing its share price drop. So as intervals speculators buy shares, to sell them again when the share price increases.
This sort of behaviour is illegal if orchestrated The share buyers bargain on the share price rising. But there are no new products.

It has now emerged that no registered Dr can prescribe biochemistry. Today is a good day to sell biochemical shares. There will never be a good day to buy them ever again.
 Drug companies use their share price to fund borrowing to make payrole. As their share price shriks, so must their payrole.
Which is why Astra Zeneca sacked all its canccer researcher 2010.

No comments: